Lewis C. Cantley
Weill Cornell Medicine
2 papers in the Anchorcite directory, published between 2007 and 2015, cited 5,484 times in total.
ORCID profileResearch topics
- HER2/EGFR in Cancer Research · 1 paper
- Cancer Genomics and Diagnostics · 1 paper
- Lung Cancer Treatments and Mutations · 1 paper
- Colorectal Cancer Treatments and Studies · 1 paper
- Vitamin C and Antioxidants Research · 1 paper
- Cancer, Hypoxia, and Metabolism · 1 paper
Frequent co-authors
- Jeffrey A. Engelman · 1 paper
- Kreshnik Zejnullahu · 1 paper
- Tetsuya Mitsudomi · 1 paper
- Youngchul Song · 1 paper
- Courtney Hyland · 1 paper
- Joon Oh Park · 1 paper
- Neal Ian Lindeman · 1 paper
- Christopher-Michael Gale · 1 paper
Papers
- MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 SignalingScience · 2007 · 4,559 citations
The epidermal growth factor receptor (EGFR) kinase inhibitors gefitinib and erlotinib are effective treatments for lung cancers with EGFR activating mutations, but these tumors invariably develop drug resistance. Here, we describe a gefitinib-sensitive lung cancer cell line that developed resistance…
- Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDHScience · 2015 · 925 citations
More than half of human colorectal cancers (CRCs) carry either KRAS or BRAF mutations and are often refractory to approved targeted therapies. We found that cultured human CRC cells harboring KRAS or BRAF mutations are selectively killed when exposed to…
Metadata from OpenAlex (CC0).